Spectroplast secures Series A Funding for silicone 3D printing technology

19.11.2024 10:34, Rita Longobardi

Venturelab alumnus Spectroplast has completed its Series A funding round, aiming to advance its silicone 3D printing technology and expand its capabilities in delivering customizable solutions for various industries.

Spectroplast, a Swiss developer of silicone-based 3D printing solutions, has closed a Series A funding round led by HZG Group, with participation from existing investor AM Ventures. The funding amount was not disclosed.

Founded in 2018 as a spin-off from ETH Zurich, Spectroplast uses its Silicone Additive Manufacturing (SAM) technology to deliver biocompatible, on-demand parts across various industries. Its TrueSil resin produces cost-effective, injection-moulding-quality parts for production runs of 1 to 50,000 units.

Silicone’s critical role in applications like gaskets, seals, and robotic grippers positions Spectroplast to address the growing demand for 3D-printed silicone solutions, especially in manufacturing and wearable electronics. Backed by leading AM-focused VCs, Spectroplast is well-placed to capitalize on this growth, bolstered by portfolio synergies with companies like Axtra3D.

The funding will support the expansion of Spectroplast’s application portfolio and customer services amid rising interest in silicone 3D printing driven by trade tensions between the US and China.

Spectroplast participated in Venture Leaders Medtech in 2021, won Venture Kick in 2019, and was ranked in the TOP 100 Swiss Startups in the same year.

Lucas Oehms (Head of IT & Project Management), Ryhor Ustsimenka (Head of Sales & Business Development), and Eva Kurisinkal (Head of Product)